Correlation Between Edgewise Therapeutics and Vera Therapeutics
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Vera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Vera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Vera Therapeutics, you can compare the effects of market volatilities on Edgewise Therapeutics and Vera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Vera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Vera Therapeutics.
Diversification Opportunities for Edgewise Therapeutics and Vera Therapeutics
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Edgewise and Vera is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Vera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vera Therapeutics and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Vera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vera Therapeutics has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Vera Therapeutics go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Vera Therapeutics
Given the investment horizon of 90 days Edgewise Therapeutics is expected to under-perform the Vera Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Edgewise Therapeutics is 1.99 times less risky than Vera Therapeutics. The stock trades about -0.13 of its potential returns per unit of risk. The Vera Therapeutics is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest 3,989 in Vera Therapeutics on August 24, 2024 and sell it today you would earn a total of 842.00 from holding Vera Therapeutics or generate 21.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Vera Therapeutics
Performance |
| Timeline |
| Edgewise Therapeutics |
| Vera Therapeutics |
Edgewise Therapeutics and Vera Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Vera Therapeutics
The main advantage of trading using opposite Edgewise Therapeutics and Vera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Vera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vera Therapeutics will offset losses from the drop in Vera Therapeutics' long position.| Edgewise Therapeutics vs. Lyra Therapeutics | Edgewise Therapeutics vs. Hookipa Pharma | Edgewise Therapeutics vs. Cingulate Warrants | Edgewise Therapeutics vs. SAB Biotherapeutics |
| Vera Therapeutics vs. Third Harmonic Bio | Vera Therapeutics vs. Cullinan Oncology LLC | Vera Therapeutics vs. Edgewise Therapeutics | Vera Therapeutics vs. Rallybio Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |